Evidence map›Paper›PMID 26825757›Full record

Trial reportJournal of health, population, and nutrition2015

Efficacy of partially hydrolyzed guar gum (PHGG) supplemented modified oral rehydration solution in the treatment of severely malnourished children with watery diarrhoea: a randomised double-blind controlled trial.

Nur Haque Alam, Hasan Ashraf, Mohammad Kamruzzaman, Tahmeed Ahmed, Sufia Islam, Maryam Kadjar Olesen, Niklaus Gyr, Remy Meier

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of health, population, and nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01821586 (Optimisation of Oral Rehydration Solution and Evaluation of the Efficacy of Benefiber), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01821586 phase2completednot on this map

Optimisation of Oral Rehydration Solution and Evaluation of the Efficacy of Benefiber(Partially Hydrolyzed Guar Gum) Containing Modified Oral Rehydration Solution in the Treatment of Severely Malnourished Children With Watery Diarrhoea

TypeinterventionalSponsorInternational Centre for Diarrhoeal Disease Research, BangladeshRan2006 to 2009Enrolled189ConditionsMalnourished Children With Watery DiarrhoeaArmsModified ORS-1, Modified ORS-2 (ReSoMal), Modified ORS-3 (Benefibre)
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Nur Haque AlamInternational Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh. nhalam@icddrb.org.
Hasan AshrafInternational Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh. nhalam@icddrb.org.
Mohammad KamruzzamanInternational Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh. drkamrul07@gmail.com.
Tahmeed AhmedInternational Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh. tahmeed@icddrb.org.
Sufia IslamDepartment of Pharmacy, East West University, Dhaka, Bangladesh. sufiaislam@gmail.com.
Maryam Kadjar OlesenNestle Health Care Nutrition, Gland, Switzerland. maryam.olesen@nestle.com.
Niklaus GyrDepartment of Internal Medicine, University Hospital, Basel, Switzerland. niklaus.gyr@unibas.ch.
Remy MeierDepartment of Gastroenterology, Hepatology and Nutrition, Kantonsspital, Liestal, Switzerland. meier.remy@outlook.com.
International Centre for Diarrhoeal Disease Research · BDEast West University · BDKantonsspital Baselland · CHNestlé (Switzerland) · CHUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine whether PHGG added ORS reduce duration of diarrhoea, stool output and enhance weight gain.

methodsIn a double-blind controlled clinical trial, 126 malnourished children (weight for length/weight for age < -3 Z-score with or without pedal edema), aged 6 - 36 months with acute diarrhoea <7 days were studied in two treatment groups; 63 received modified WHO ORS (Na 75, K 40, Cl 87, citrate 7, glucose 90 mmol/L) with PHGG 15 g/L (study group); 63 received modified WHO ORS without PHGG (control). Other treatments were similar in both groups. The study protocol was approved by Ethics Committee of icddr,b; the study was carried out at the Dhaka Hospital.

resultsThe mean duration of diarrhoea (h) was significantly shorter in children of the study group (Study vs. control, mean ± SD, 57 ± 31 vs. 75 ± 39, p = 0.01). Although there was a trend in stool weight reduction in children receiving ORS with PHGG (study vs. control, stool weight (g), mean ± SD; 1(st) 24 hour, 854.03 ± 532.15 vs. 949.11 ± 544.33, p = 0.32; 2(nd) 24 hour, 579.84 ± 466.01 vs. 761.26 ± 631.64, p = 0.069; 3(rd) 24 hour, 385.87 ± 454.09 vs. 495.73 ± 487.61, p = 0.196), especially in 2(nd) 24 h period, the difference was not statistically significant. The mean time (day) to attain weight for length 80% of NCHS median without edema was significantly shorter in the study group (study vs. control, mean ± SD, 4.5 ± 2.6 vs. 5.7 ± 2.8, p = 0.027).

conclusionPHGG added to ORS substantially reduced duration of diarrhoea. It also enhanced weight gain. Further studies might substantiate to establish its beneficial effect. CLINICAL TRIAL REGISTRATION NUMBER: NCT01821586.

Indexed as

Child Nutritional Physiological PhenomenaFluid TherapyBangladeshChild, PreschoolDiarrheaDiarrhea, InfantileDietary FiberDouble-Blind MethodFemaleGalactansHospitals, UrbanHumansHydrolysisInfantKaplan-Meier EstimateMaleDietary FiberGalactansguar gumMannansPlant GumsRehydration Solutions

Identifiers

PMID26825757
PMCPMC5026008
OpenAlexW2157826233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.